333 filings
Page 2 of 17
8-K
b8ya2 gumxl0nrw200
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
PX14A6G
hbchab
6 Jul 23
Letter to shareholders
8:33am
8-K
nk2 kzrb1c2f
3 Jul 23
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
6:06am
PX14A6G
61ep17x87vkk9
1 Jun 23
Letter to shareholders
2:01pm
S-8
b7q ukm8r
26 May 23
Registration of securities for employees
4:39pm
8-K
t3qfd095wy algh48bc
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
h407xdffvgk6p
17 May 23
Letter to shareholders
4:00pm
PX14A6G
tv9btvywtlqgq099x5q
11 May 23
Letter to shareholders
11:34am
DEFA14A
ptter
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
hlez7ocdp7k
5 May 23
Letter to shareholders
11:17am
8-K
rchcb
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
lg1jkyx0kje9
3 May 23
Letter to shareholders
2:53pm
DEFA14A
uopb9s
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
wp3xaxt
28 Apr 23
Additional proxy soliciting materials
4:03pm
PX14A6G
quah7b8kgku lr2nxwje
26 Apr 23
Letter to shareholders
10:20am
8-K
2y946q23
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
8-K
a7c9aawrtxwqf gc43u
13 Mar 23
Other Events
6:03am